| Universal screening for methicillin-resistant Staphylococcus aureus at hospital admission and nosocomial infection in surgical patients S Harbarth, C Fankhauser, J Schrenzel, J Christenson, P Gervaz, ... Jama 299 (10), 1149-1157, 2008 | 654 | 2008 |
| Impact of Combined Low-Level Mupirocin and Genotypic Chlorhexidine Resistance on Persistent Methicillin-Resistant Staphylococcus aureus Carriage After … AS Lee, M Macedo-Vinas, P François, G Renzi, J Schrenzel, N Vernaz, ... Clinical infectious diseases 52 (12), 1422-1430, 2011 | 197 | 2011 |
| Temporal effects of antibiotic use and hand rub consumption on the incidence of MRSA and Clostridium difficile N Vernaz, H Sax, D Pittet, P Bonnabry, J Schrenzel, S Harbarth Journal of Antimicrobial Chemotherapy 62 (3), 601-607, 2008 | 192 | 2008 |
| The impact of antibiotic use on the incidence and resistance pattern of extended‐spectrum beta‐lactamase‐producing bacteria in primary and secondary healthcare settings MA Aldeyab, S Harbarth, N Vernaz, MP Kearney, MG Scott, ... British journal of clinical pharmacology 74 (1), 171-179, 2012 | 130 | 2012 |
| Modelling the impact of antibiotic use on antibiotic-resistant Escherichia coli using population-based data from a large hospital and its surrounding community N Vernaz, B Huttner, D Muscionico, JL Salomon, P Bonnabry, ... Journal of Antimicrobial Chemotherapy 66 (4), 928-935, 2011 | 116 | 2011 |
| Dynamics of active pharmaceutical ingredients loads in a Swiss university hospital wastewaters and prediction of the related environmental risk for the aquatic ecosystems S Daouk, N Chèvre, N Vernaz, C Widmer, Y Daali, S Fleury-Souverain Science of The Total Environment 547, 244-253, 2016 | 83 | 2016 |
| NAFLD and MAFLD as emerging causes of HCC: A populational study S Myers, I Neyroud-Caspar, L Spahr, K Gkouvatsos, E Fournier, E Giostra, ... Jhep Reports 3 (2), 100231, 2021 | 81 | 2021 |
| Patented drug extension strategies on healthcare spending: a cost-evaluation analysis N Vernaz, G Haller, F Girardin, B Huttner, C Combescure, P Dayer, ... PLoS medicine 10 (6), e1001460, 2013 | 75 | 2013 |
| Temporal variability of antibiotics fluxes in wastewater and contribution from hospitals S Coutu, L Rossi, DA Barry, S Rudaz, N Vernaz PLoS One 8 (1), e53592, 2013 | 69 | 2013 |
| Trends in mupirocin resistance in meticillin-resistant Staphylococcus aureus and mupirocin consumption at a tertiary care hospital AS Lee, M Macedo-Vinas, P Francois, G Renzi, N Vernaz, J Schrenzel, ... Journal of Hospital Infection 77 (4), 360-362, 2011 | 63 | 2011 |
| Temporal effects of antibiotic use and Clostridium difficile infections N Vernaz, K Hill, S Leggeat, D Nathwani, G Philips, P Bonnabry, P Davey Journal of antimicrobial chemotherapy 63 (6), 1272-1275, 2009 | 63 | 2009 |
| Activity and impact on antibiotic use and costs of a dedicated infectious diseases consultant on a septic orthopaedic unit I Uçkay, N Vernaz-Hegi, S Harbarth, R Stern, L Legout, L Vauthey, T Ferry, ... Journal of Infection 58 (3), 205-212, 2009 | 63 | 2009 |
| Quasiexperimental study of the effects of antibiotic use, gastric acid-suppressive agents, and infection control practices on the incidence of Clostridium difficile-associated … MA Aldeyab, S Harbarth, N Vernaz, MP Kearney, MG Scott, C Funston, ... Antimicrobial agents and chemotherapy 53 (5), 2082-2088, 2009 | 62 | 2009 |
| Multihospital outbreak of Clostridium difficile ribotype 027 infection: epidemiology and analysis of control measures MA Aldeyab, MJ Devine, P Flanagan, M Mannion, A Craig, MG Scott, ... Infection Control & Hospital Epidemiology 32 (3), 210-219, 2011 | 61 | 2011 |
| Prioritization methodology for the monitoring of active pharmaceutical ingredients in hospital effluents S Daouk, N Chèvre, N Vernaz, P Bonnabry, P Dayer, Y Daali, ... Journal of Environmental Management 160, 324-332, 2015 | 59 | 2015 |
| Impact of a region wide antimicrobial stewardship guideline on urinary tract infection prescription patterns C Slekovec, J Leroy, N Vernaz-Hegi, JP Faller, D Sekri, B Hoen, D Talon, ... International journal of clinical pharmacy 34, 325-329, 2012 | 52 | 2012 |
| Staphylococcus aureus and methicillin resistance in Switzerland: regional differences and trends from 2004 to 2014. F Olearo, WC Albrich, N Vernaz, S Harbarth, AO Kronenberg Swiss medical weekly 146 (w14339), w14339, 2016 | 40 | 2016 |
| Vulnerable patients forgo health care during the first wave of the Covid-19 pandemic S Baggio, N Vernaz, H Spechbach, J Salamun, F Jacquerioz, S Stringhini, ... Preventive medicine 150, 106696, 2021 | 33 | 2021 |
| Cost-effectiveness of HLA-DQB1/HLA-B pharmacogenetic-guided treatment and blood monitoring in US patients taking clozapine FR Girardin, A Poncet, A Perrier, N Vernaz, M Pletscher, C F. Samer, ... The pharmacogenomics journal 19 (2), 211-218, 2019 | 33 | 2019 |
| Early experimental COVID-19 therapies: associations with length of hospital stay, mortality and related costs N Vernaz, T Agoritsas, A Calmy, A Gayet-Ageron, G Gold, A Perrier, ... Swiss Medical Weekly 150 (5153), w20446-w20446, 2020 | 28 | 2020 |
